» Articles » PMID: 37895129

Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Oct 28
PMID 37895129
Authors
Affiliations
Soon will be listed here.
Abstract

Kawasaki disease (KD) is an acute febrile vasculitis that occurs mostly in children younger than five years. KD involves multiple intricately connected inflammatory reactions activated by a cytokine cascade. Despite therapeutic advances, coronary artery damage may develop in some patients, who will be at risk of clinical cardiovascular events and even sudden death. The etiology of KD remains unclear; however, it may involve both genetic and environmental factors leading to aberrant inflammatory responses. Given the young age of onset, prenatal or perinatal exposure may be etiologically relevant. Multisystem inflammatory syndrome in children, a post-infectious hyper-inflammatory disorder associated with severe acute respiratory syndrome coronavirus 2, has features that overlap with those of KD. Available evidence indicates that vascular endothelial dysfunction is a critical step in the sequence of events leading to the development of cardiovascular lesions in KD. Oxidative stress and the dysregulation of the nitric oxide (NO) system contribute to the pathogenesis of inflammatory responses related to this disease. This review provides current evidence and concepts highlighting the adverse effects of oxidative injury and NO system derangements on the initiation and progression of KD and potential therapeutic strategies for cardiovascular pathologies in affected children.

Citing Articles

Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies in Kawasaki Disease.

Paolini L, Guida F, Calvaruso A, Andreozzi L, Pierantoni L, Lanari M Int J Mol Sci. 2025; 25(24.

PMID: 39769085 PMC: 11676170. DOI: 10.3390/ijms252413322.


A nomogram prediction of coronary artery dilation in Kawasaki diseases based on mtDNA copy number.

Peng M, Yue P, Zhang Y, Li H, Hua Y, Li Y Front Immunol. 2024; 15:1448558.

PMID: 39206185 PMC: 11349549. DOI: 10.3389/fimmu.2024.1448558.


Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients.

Tsuge M, Ichihara E, Hasegawa K, Kudo K, Tanimoto Y, Nouso K Int J Mol Sci. 2024; 25(15).

PMID: 39125944 PMC: 11313210. DOI: 10.3390/ijms25158370.


Hydrogen Gas Inhalation Treatment for Coronary Artery Lesions in a Kawasaki Disease Mouse Model.

Shih W, Yeh T, Chen K, Leu S, Liu S, Huang Y Life (Basel). 2024; 14(7).

PMID: 39063551 PMC: 11277616. DOI: 10.3390/life14070796.


VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes.

Ricke D, Smith N Life (Basel). 2024; 14(3).

PMID: 38541678 PMC: 10971466. DOI: 10.3390/life14030353.


References
1.
Rhim J, Kang H, Han J, Lee K . A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases. Front Pediatr. 2019; 7:202. PMC: 6536658. DOI: 10.3389/fped.2019.00202. View

2.
Sonoda K, Ohtake K, Uchida H, Ito J, Uchida M, Natsume H . Dietary nitrite supplementation attenuates cardiac remodeling in l-NAME-induced hypertensive rats. Nitric Oxide. 2017; 67:1-9. DOI: 10.1016/j.niox.2017.04.009. View

3.
Ishikawa T, Iwashima S . Endothelial dysfunction in children within 5 years after onset of Kawasaki disease. J Pediatr. 2013; 163(4):1117-21. DOI: 10.1016/j.jpeds.2013.04.046. View

4.
Gonzalez A, Townsend J, Pinzone A, Hoffman J . Supplementation with Nitric Oxide Precursors for Strength Performance: A Review of the Current Literature. Nutrients. 2023; 15(3). PMC: 9921013. DOI: 10.3390/nu15030660. View

5.
Tsukahara H, Kikuchi K, Matsuda M, Saito M, Hata I, Tsuchida S . Endogenous nitric oxide production in Kawasaki disease. Scand J Clin Lab Invest. 1997; 57(1):43-7. DOI: 10.3109/00365519709057817. View